IR情報

2020/10/13~2021/03/10

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2021
03/10297300294297+0.34%62,20086億8757万-4.5%
03/09291296286296+2.42%60,10086億5832万-5.13%
03/08288295287289+1.4%82,90084億5356万-7.67%
03/05288289280285-1.04%157,10083億3656万-9.52%
03/04293293285288-2.7%180,60084億2431万-9.15%
03/03297297293296-0.34%48,50086億5832万-6.92%
03/02295300293297+1.02%82,60086億8757万-7.19%
03/0115:30 第10回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ
03/01295298293294-0.34%69,90085億9982万-8.41%
02/26300300293295-1.99%131,90086億2907万-8.39%
02/25300303300301+1.01%41,80088億458万-6.81%
02/24301307298298-1%115,50087億1682万-8.02%
02/22299305299301+0.67%87,90088億458万-7.1%
02/19309309298299-1.97%103,50087億4607万-8%
02/18311313305305-2.56%65,60089億2158万-6.15%
02/17298313298313+5.03%118,00091億5559万-3.4%
02/16306307297298-3.25%198,70087億1682万-8.02%
02/15325328307308-9.14%431,80090億933万-4.94%
02/1215:30 2020年12月期決算短信〔日本基準〕(連結)
02/1215:30 2020年12月期通期決算説明資料
02/12339341331339-1.17%130,80099億1612万+4.95%
02/10341344331343+0.59%150,400100億3312万+6.85%
02/09345348340341-0.58%103,60099億7462万+7.23%
02/08350350339343-2%209,100100億3312万+8.54%
02/05337350333350+5.11%239,800102億3788万+11.46%
02/04332336331333-0.6%56,00097億4061万+7.07%
02/03328338328335+0.9%123,50097億9911万+8.41%
02/02328332322332+1.22%48,70097億1136万+8.14%
02/01320328313328+1.86%80,40095億9436万+7.54%
01/29326333321322-2.13%125,40094億1885万+6.62%
01/28325331323329-0.6%73,60096億2361万+9.3%
01/27327333327331+0.3%71,40096億8211万+10.7%
01/26333335326330-1.79%124,80096億5286万+11.11%
01/25325336323336+3.38%197,00098億2836万+13.51%
01/22323325321325+0.31%83,70095億660万+10.54%
01/21321325320324+1.25%120,70094億7735万+10.58%
01/20331331318320+1.59%259,20093億6035万+9.59%
01/208:45 眼科手術補助剤「DW-1002」のカナダにおける承認取得のお知らせ
01/19307317306315+2.61%93,50092億1409万+8.25%
01/18311312300307-0.65%78,60089億8008万+5.5%
01/15297309297309+4.04%303,90090億3858万+6.55%
01/1415:30 業績予想の修正に関するお知らせ
01/14297300296297-0.34%54,90086億8757万+2.41%
01/133013042982980%79,30087億1682万+2.41%
01/12297301294298+1.02%158,40087億1682万+2.05%
01/08286296286295+2.79%105,90086億2907万+0.68%
01/07293293286287-1.37%71,20083億9506万-2.38%
01/06282292282291+3.19%103,60085億1207万-1.36%
01/05281286279282-1.05%95,40082億4881万-5.05%
01/04289289280285-1.38%118,50083億3656万-4.68%
2020
12/30280290280289+2.12%216,20084億5356万-3.99%
12/29270283269283+4.43%179,70082億7806万-6.29%
12/28276278268271-2.87%387,90079億2704万-10.86%
12/25280285278279-1.06%175,30081億6105万-8.82%
12/24276287275282+2.55%265,30082億4881万-8.44%
12/23276282275275-1.08%209,20080億4405万-11.29%
12/22284286278278-3.47%213,90081億3180万-10.9%
12/21290292285288-1.37%161,40084億2431万-8.28%
12/18290295286292+0.34%173,60085億4132万-7.3%
12/17296297290291-1.02%211,80085億1207万-8.2%
12/16299300292294-1.67%177,40085億9982万-7.55%
12/15301303298299-0.99%64,40087億4607万-6.27%
12/14299307297302+1.68%132,00088億3383万-5.63%
12/11292298292297+0.34%142,30086億8757万-7.48%
12/10297301296296-1.33%84,00086億5832万-8.07%
12/09304305295300-2.6%270,00087億7533万-7.41%
12/08311312303308-1.28%177,90090億933万-4.94%
12/07320321312312-2.19%207,20091億2634万-4%
12/04321324318319-0.62%98,50093億3110万-1.85%
12/03324326320321-1.23%105,60093億8960万-1.53%
12/02321327321325+0.31%71,80095億660万-0.31%
12/01324327320324-1.22%151,80094億7735万-0.61%
11/3015:30 ファシリティ契約に基づく第10回新株予約権(行使価額修正条項付)の行使停止要請通知に関するお知らせ
11/30331334328328-0.91%57,00095億9436万+0.31%
11/27327333327331+0.61%132,60096億8211万+1.22%
11/263313313283290%55,80096億2361万+0.61%
11/25332335327329-1.5%108,30096億2361万+0.3%
11/24327339326334+2.14%183,20097億6986万+1.83%
11/20326327323327+0.31%58,70095億6510万-0.61%
11/19327327321326-0.31%73,10095億3585万-1.21%
11/18322330320327+1.55%100,80095億6510万-1.21%
11/17328328321322-0.92%69,00094億1885万-3.01%
11/16324329322325-0.31%82,10095億660万-2.69%
11/13321328321326-0.61%79,80095億3585万-2.69%
11/1215:30 2020年12月期第3四半期決算短信〔日本基準〕(連結)
11/12326331324328+0.31%77,90095億9436万-2.67%
11/11323329322327+1.24%78,50095億6510万-3.25%
11/10328328322323-0.62%76,10094億4810万-4.72%
11/09331331318325+0.62%120,30095億660万-4.69%
11/06324330322323-0.62%93,30094億4810万-5.56%
11/053223293223250%78,20095億660万-5.25%
11/04322329319325+2.52%130,30095億660万-5.52%
11/02317321313317+0.32%107,90092億7259万-8.12%
10/30326328315316-3.07%206,30092億4334万-8.93%
10/29323329321326-1.51%140,50095億3585万-6.32%
10/283333383263310%101,60096億8211万-5.16%
10/27327335326331-0.6%153,40096億8211万-5.7%
10/278:50 神経疼痛治療薬「DW-5LBT」の米国における承認申請受理のお知らせ
10/263323443323330%123,50097億4061万-5.67%
10/23329334321333+1.52%164,40097億4061万-6.2%
10/22340340322328-3.53%324,80095億9436万-8.12%
10/21342344340340-0.58%120,00090億5083万-5.29%
10/20346349341342-1.72%135,60091億407万-5%
10/19344351343348+0.87%70,80092億6379万-3.87%
10/16350352344345-1.15%141,10091億8393万-4.96%
10/15358358347349-3.06%279,30092億9041万-4.12%
10/14358364358360-0.55%90,70095億8323万-1.37%
10/133643643583620%72,50096億3647万-0.82%